| Patents for A61K 49 - Preparations for testing in vivo (35,376) |
|---|
| 03/18/2010 | WO2010028817A2 Medical system |
| 03/18/2010 | WO2009154425A9 Multimodal imaging method using nano-emulsion comprising optical nano-particles and perfluorocarbons |
| 03/18/2010 | US20100071079 Methods for treating autoimmune and chronic inflammatory conditions using antagonists of cd30 or cd30l |
| 03/18/2010 | US20100069726 Compositions and methods for rapid one-step diagnosis |
| 03/18/2010 | US20100069669 Preparation of Iodixanol |
| 03/18/2010 | US20100069628 Multidentate AZA Ligands Able to Complex Metal Ions And The Use Thereof In Diagnostics And Therapy |
| 03/18/2010 | US20100068255 liposomes comprising humanized Fab fragment of monoclonal antibody that binds cell surface markers, amphipathic vesicle-forming lipid and polyethylene glycol derivatized lipid, capable of inhibiting growth and proliferation of target cells; HER growth factor receptors |
| 03/18/2010 | US20100068250 Abuse Potential Reduction in Abusable Substance Dosage Form |
| 03/18/2010 | US20100068153 Ex vivo activatable final dosage form |
| 03/18/2010 | US20100068151 Multimodality molecular imaging with therapeutic conjugates |
| 03/18/2010 | US20100068150 Selective Caspase Inhibitors |
| 03/18/2010 | US20100068148 Enhanced resolution of tumor metastasis using a skin flap model |
| 03/18/2010 | US20100068147 Dengue diagnosis and treatment |
| 03/18/2010 | US20100068146 Method for Improving Brain Fitness with Consumable Products |
| 03/18/2010 | US20100068145 Bispecific fusion protein having therapeutic and diagnostic potential |
| 03/18/2010 | US20100068144 Nonlinear optical detection of molecules comprising an unnatural amino acid possessing a hyperpolarizability |
| 03/18/2010 | US20100068143 Metal-polymer coordination complex incorporating phosphorus atoms and applications using such a complex |
| 03/18/2010 | US20100068142 Melanoma repopulating cells |
| 03/18/2010 | US20100068141 Use of heat shock to treat ocular disease |
| 03/18/2010 | US20100068138 Structurally rigid dopamine d3 receptor selective ligands and process for making them |
| 03/18/2010 | CA2736368A1 Imaging agents of fibrotic diseases |
| 03/18/2010 | CA2736245A1 Methods for the administration of iloperidone |
| 03/17/2010 | EP2163642A1 Nucleic acid constructs, vascular cells transformed therewith, pharmaceutical compositions and methods utilizing same for inducing angiogenesis |
| 03/17/2010 | EP2162157A1 Use of 3-alkanoyloxymethoxycarbonyl nitroxide esters as oximetry probes for measurement of oxygen status in tissues |
| 03/17/2010 | CN101674852A Multi-functional polyglutamate drug carriers |
| 03/17/2010 | CN101670107A Multifunctional nuclear shell structure drug carrier material and preparation method thereof |
| 03/17/2010 | CN101670095A Pharmaceutical composition for treating embolism and preparation method thereof |
| 03/16/2010 | US7680527 Method and apparatus for imaging abdominal aorta and aortic aneurysms |
| 03/16/2010 | US7680524 Magnetic fluid detection method and magnetic fluid detection apparatus |
| 03/16/2010 | US7678775 ILK inhibitors for the treatment of renal disease |
| 03/16/2010 | US7678363 treating a nervous system disorder related to depression in a subject or patient in need thereof by administering a composition consisting of sabcomeline and a selective serotonin reuptake inhibitor |
| 03/16/2010 | CA2410023C Coated nanoparticles |
| 03/16/2010 | CA2397495C Composition for detecting beta-1,3-glucan, preparation method thereof and diagnostic kit detecting beta-1,3-glucan |
| 03/11/2010 | WO2010028389A1 Image-guided energy deposition for targeted drug delivery |
| 03/11/2010 | WO2010028216A2 Porphyrazine optical and dual optical/mr contrast and therapeutic agents |
| 03/11/2010 | WO2010028156A2 Dual modality detection of apoptosis |
| 03/11/2010 | WO2010027387A1 Transdermal delivery in small animals or humans |
| 03/11/2010 | WO2010026743A1 Reagent for measuring hypoxic environment |
| 03/11/2010 | WO2010026357A1 Method and device for marking a medium, and marker usable in such a method |
| 03/11/2010 | WO2010008478A3 Improved techniques for magnetic particle imaging |
| 03/11/2010 | WO2009143388A3 Luminescent multimodal nanoparticle probe system and method of manufacture thereof |
| 03/11/2010 | US20100062006 Treatment of stomach cancer with steroid compounds and precipitation |
| 03/11/2010 | US20100061938 Mri trackable drug delivery particles, uses and methods thereof |
| 03/11/2010 | US20100061937 Delivery of contrasting agents for magnetic resonance imaging |
| 03/11/2010 | US20100061936 Unnatural amino acids capable of covalently modifying protein phosphatases and their use as general and specific inhibitors and probes |
| 03/11/2010 | US20100061935 Methods of using sustained release aminopyridine compositions |
| 03/11/2010 | US20100061934 Methods for diagnosis or treatment of amyloidosis by targeting hyper-sulfated proteoglycans present in amyloid |
| 03/11/2010 | US20100061933 Pharmaceutical composition comprising anti-hb-egf antibody as active ingredient |
| 03/11/2010 | US20100061932 Peptides useful as cell-penetrating peptides |
| 03/11/2010 | US20100061930 ErbB-2 RECEPTOR TARGETING PEPTIDE |
| 03/11/2010 | US20100061929 Neoplasia targeting peptides and methods of using the same |
| 03/11/2010 | CA2735966A1 Method and device for marking a medium, and marker usable in such a method |
| 03/11/2010 | CA2734508A1 Transdermal delivery in small animals or humans |
| 03/10/2010 | EP2161039A1 Method for testing an agent for strokes in humans with a non-human stroke model |
| 03/10/2010 | EP2161020A1 Chelating amphiphilic polymers |
| 03/10/2010 | EP2160617A1 Hyperpolarization of compounds for nmr, in particular by means of phip |
| 03/10/2010 | EP2160475A2 Markers and methods for assessing and treating crohn's disease and related disorders |
| 03/10/2010 | CN101668546A Quantum theory-based continuous precision nmr/mri: method and apparatus |
| 03/10/2010 | CN100593421C Magnetic resonance imaging contrast agent having bone tissue targeting detection based on metal fullerene and the preparation thereof |
| 03/09/2010 | US7674463 Method of inhibiting angiogenesis by administration of a corticotropin releasing factor receptor 2 agonist |
| 03/04/2010 | WO2010023670A2 Methods for covalently attaching a polymer to a methionine residue in proteins and peptides |
| 03/04/2010 | WO2009151687A3 Dendrimer conjugates |
| 03/04/2010 | WO2009147492A3 Aqueous solution comprising iodine and potassium iodide as radiologic marker |
| 03/04/2010 | WO2009126835A3 Magnetic nanoparticle and method for imaging t cells |
| 03/04/2010 | WO2009081287A3 Polysaccharide nanoparticles |
| 03/04/2010 | WO2009040811A3 Polymer nanoparticles coated by magnetic metal oxide and uses thereof |
| 03/04/2010 | WO2009009179A3 Non-invasive molecular imaging of cellular histone deacetylase substrate using magnetic resonance spectroscopy (mrs) or positron emission tomography (pet) |
| 03/04/2010 | US20100055043 Poly-Halo Metal X-ray Contrast Agents |
| 03/04/2010 | US20100055042 Enhancing Clot Busting Medication in Stroke with Directed Drug Convection using Magnetic Nano-Particles |
| 03/04/2010 | US20100055041 Nanotracer for in-situ gastric cancer detection |
| 03/04/2010 | US20100055040 Optical Imaging Contrast Agents |
| 03/04/2010 | US20100055039 Non-invasive methods of monitoring engrafted stem cells and methods for isolation of skeletal muscle stem cells |
| 03/04/2010 | US20100055038 Methods for Predicting Effectiveness of Apheresis Therapy for Heart Failure |
| 03/04/2010 | US20100055037 Treatment, prevention, and reversal of alcohol-induced brain disease |
| 03/04/2010 | US20100055032 Methods for vascular imaging using nanoparticulate contrast agents |
| 03/04/2010 | CA2735118A1 Butyrylcholinesterase ligands as diagnostic tools and treatment for diseases of the nervous system |
| 03/03/2010 | EP2157911A2 Assessment of blood-brain barrier disruption |
| 03/03/2010 | EP1756270B1 Diagnosis and treatment of myeloid and lymphoid cell cancers with chlorotoxin or a derivative |
| 03/03/2010 | EP1404372B1 Pharmaceutical formulations and ligands for use therein; mimetics for uea-1 |
| 03/03/2010 | EP1226153B1 Fluorescent cobalamins and uses thereof |
| 03/03/2010 | CN101663050A Visualization of biological material by the use of coated contrast agents |
| 03/03/2010 | CN101658680A Medical environment-friendly sterilization ultrasound coupling agent and preparation method thereof |
| 03/03/2010 | CN101658679A Contrast medium of dual-sector targeted magnetic resonance imaging and preparation thereof |
| 03/03/2010 | CN101658678A Propagation agent and propagation method for natural killer cell |
| 03/03/2010 | CN100592921C Activatable particles, preparations and uses. |
| 03/02/2010 | US7671015 treating an ischemic insult to neurons in a subject's brain by administering to the brain of a subject in need of such treatment an effective amount of aequorin |
| 03/02/2010 | US7670763 determining sperm quality, and different storage media's effect thereon; male fertility |
| 03/02/2010 | US7670600 increased in vivo half-lives due to the presence of an immunoglobulin G (IgG) constant domain; pharmacokinetics; diagnosis or immunotherapy; antibody conjugates; palivizumab |
| 03/02/2010 | US7670592 Polyvinyl alcohol microspheres, injectable solutions and therapeutic uses of the same |
| 03/02/2010 | US7670590 Perturbed membrane-binding compounds and methods of using the same |
| 02/25/2010 | WO2010021519A2 T1-t2 dual modal mri contrast agents |
| 02/25/2010 | WO2010020673A2 Transcutaneous organ function measurement |
| 02/25/2010 | WO2009138499A3 Biomarkers for depression |
| 02/25/2010 | WO2009136764A3 Dual-modality pet/mri contrast agents |
| 02/25/2010 | WO2009117567A3 Substituted fullerenes as mri contrast agents |
| 02/25/2010 | WO2009016181A3 Optical imaging agents |
| 02/25/2010 | WO2005081873A9 Il-13 mutein proteins, antibodies, compositions, methods and uses |
| 02/25/2010 | US20100047182 Immunotherapy for immune suppressed patients |
| 02/25/2010 | US20100047181 Mixture of a vanilloid receptor agonist and a substance inhibiting nerve regeneration, use thereof for producing a painkiller, and method for applying said painkiller |
| 02/25/2010 | US20100047180 Iron/Iron Oxide Nanoparticle and Use Thereof |